Shuttle Walking Test to predict breathing problems after lung surgery
Official title: Predictive Value of the Shuttle Walking Test for Postoperative Dyspnea in Chronic Respiratory Disease Patients Undergoing Lung Resection: A Prospective Observational Study
Run by Seoul National University Bundang Hospital · NCT07102589 · Data updated 2026-11-12
This project will use a simple shuttle walking test before lung surgery to see if it predicts breathing problems and quality-of-life changes in people with chronic lung disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Seoul National University Bundang Hospital Academic / other |
| Locations | 1 site (Seongnam-si, Not Required For This Country) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | January 31, 2026 |
| Study ends | May 31, 2026 |
| Registry record updated | August 4, 2025 |
| Trial ID | NCT07102589 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 or older with COPD, ILD, or bronchiectasis who are scheduled for lung resection and are able to perform the shuttle walking tests and complete questionnaires are ideal candidates.
✕Probably not a fit
People who cannot walk safely, cannot read Korean, decline participation, or are not undergoing lung resection are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study enrolling adults with chronic respiratory disease who are scheduled for lung resection. Participants will perform the incremental and endurance Shuttle Walking Tests (ISWT + ESWT) before surgery and complete dyspnea and EQ-5D questionnaires before and three months after the operation. Results will be compared with usual preoperative risk tools (such as DLCO or CPET when available) to determine whether SWT performance is associated with postoperative dyspnea and quality-of-life changes. The SWT is a simpler, lower-cost test that may be more widely available than standard exercise testing.
Why it matters
Potential benefit: If successful, the shuttle walking test could provide a low-cost way to identify patients at higher risk of persistent breathlessness or poorer quality of life after lung resection, helping clinicians plan care and counsel patients.
How similar studies have gone: The Shuttle Walking Test has been used successfully to measure exercise capacity and often correlates with CPET or DLCO, but using it specifically to predict postoperative dyspnea after lung resection is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Age ≥ 40 years * Scheduled for surgical lung resection (e.g., for lung cancer or benign tumor) * Diagnosis of chronic respiratory disease (COPD, ILD, or bronchiectasis) * Able to perform Shuttle Walking Test (ISWT + ESWT) before surgery * Able to complete pre- and postoperative symptom questionnaires (dyspnea, EQ-5D) Exclusion Criteria: * \- Illiteracy or inability to read study materials * Inability to communicate in Korean * Decline or withdraw consent * Severe lower limb disability interfering with walking (e.g., fracture, paralysis)
Where it's running
-
Seoul National University Bundang Hospital
Seongnam-si, Not Required For This Country, South Korea Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using entropy to detect sleep breathing problems in chronic lung disease
This project will test whether entropy measurements from simple overnight oxygen and pulse recordings can find sleep-disordered breathing in adults with chronic lung conditions such as COPD, asthma, bronchiectasis, and interstitial lung disease.
-
Using the Lung Sliding Index to distinguish common lung diseases
This project will test whether the Lung Sliding Index (LSI) measured by bedside ultrasound can tell apart various lung conditions in adults with lung disease and in healthy volunteers.
-
Bailing Capsules with Guben Kechuan Granules for stable bronchiectasis
This trial will try whether adding Bailing Capsules plus Guben Kechuan Granules to standard Western treatment reduces acute exacerbations in adults with stable bronchiectasis.
-
Monitoring vital signs in patients using long-term oxygen therapy
This study tests if using a wearable device to monitor vital signs can improve the quality of life for adults with COPD and interstitial lung disease who are on long-term oxygen therapy.
-
Using breath analysis to identify multiple lung diseases
This study is testing if analyzing breath samples can help identify different lung diseases like lung cancer and COPD in a large group of 10,000 people.
-
Using smartphone technology to evaluate airway conditions
This study is testing if smartphone technology can help check lung health and spot breathing problems in both healthy people and those with asthma or COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.